FDA inspection
Novugen Oncology Sdn. Bhd.: FDA inspection ending Jul 21, 2023
FDA inspection 1210629 · Voluntary Action Indicated (VAI) · Labu
Key facts
| Inspection ID | 1210629 |
|---|---|
| Firm | Novugen Oncology Sdn. Bhd. |
| FEI number | 3022275118 |
| Address | No 47 Jalan Lengkuk Teknologi 2, Taman Teknologi Enstek Fasa 1 Techpark@Enstek |
| City | Labu |
| Fiscal year | 2023 |
| Inspection end date | Jul 21, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data